[F]Fluoro-2-deoxy-2--glucose versus 3′-deoxy-3′-[F]fluorothymidine for defining hematopoietically active pelvic bone marrow in gynecologic patients

We compared [18F]fluoro-2-deoxy-2-d-glucose (FDG) versus 3′-deoxy-3′-[18F]fluorothymidine (FLT) for the purpose of identifying active pelvic bone marrow (BM), quantifying its locational variation, and determining which technique is likely to be better for BM-sparing radiation planning.

from Rathiotherapy via ola Kala on Inoreader http://ift.tt/1OeSHdL
via IFTTT

from #Med Blogs by Alexandros G.Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/1OQB070
via IFTTT